首页 > 最新文献

NUCLEAR MEDICINE REVIEW最新文献

英文 中文
Presentation of genital tuberculosis detected on FDG PET/CT scan resembling a primary gynecologic tumor and metastases. FDG PET/CT扫描发现生殖器结核,类似于原发性妇科肿瘤和转移瘤。
IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-01-01 DOI: 10.5603/NMR.2021.0022
Inci Uslu Biner, Ebru Tatci, Ozlem Ozmen, Mujgan Güler, Fatma Benli

Gastric cancer (GC) is a common cause of cancer-related deaths in the world. In addition to the patient's clinical history and clinical examination, nuclear medicine tools are required for diagnosis. [¹⁸F]FDG PET/CT has been commonly used for cancer patients for staging, restaging, evaluation of treatment response. This study aimed to review the current literature on the role of [¹⁸F]FDG PET/CT for GC management.

胃癌(GC)是世界上癌症相关死亡的常见原因。除了患者的临床病史和临床检查外,诊断还需要核医学工具。[¹⁸F]FDG PET/CT已广泛用于癌症患者的分期、再分期和治疗反应评估。本研究旨在回顾[¹⁸F]FDG PET/CT在气相色谱管理中的作用。
{"title":"Presentation of genital tuberculosis detected on FDG PET/CT scan resembling a primary gynecologic tumor and metastases.","authors":"Inci Uslu Biner,&nbsp;Ebru Tatci,&nbsp;Ozlem Ozmen,&nbsp;Mujgan Güler,&nbsp;Fatma Benli","doi":"10.5603/NMR.2021.0022","DOIUrl":"https://doi.org/10.5603/NMR.2021.0022","url":null,"abstract":"<p><p>Gastric cancer (GC) is a common cause of cancer-related deaths in the world. In addition to the patient's clinical history and clinical examination, nuclear medicine tools are required for diagnosis. [¹⁸F]FDG PET/CT has been commonly used for cancer patients for staging, restaging, evaluation of treatment response. This study aimed to review the current literature on the role of [¹⁸F]FDG PET/CT for GC management.</p>","PeriodicalId":44718,"journal":{"name":"NUCLEAR MEDICINE REVIEW","volume":"24 2","pages":"104-105"},"PeriodicalIF":0.9,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39303514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sentinel lymph node biopsy in upper tract urothelial cancers: an experience with intraoperative radiotracer injection. 上尿路上皮癌前哨淋巴结活检:术中放射示踪剂注射的经验。
IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-01-01 DOI: 10.5603/NMR.2021.0013
Leili Zarifmahmoudi, Hamidreza Ghorbani, Ramin Sadeghi, Salman Soltani, Kayvan Sadri, Mahmoud Tavakkoli, Maliheh Keshvari

Background: The feasibility of the sentinel node mapping in upper tract urothelial cancers (UTUC) was evaluated, using a radiotracer as the mapping material.

Material and methods: To identify the sentinel lymph nodes, 37 MBq of [99mTc] phytate was injected in five patients with the renal pelvis or ureter cancer, who were candidates for ureterectomy and lymphadenectomy. The radiotracer was injected in a peritumoral fashion following the surgical exposure of the tumour. The sentinel lymph nodes were detected using a handheld gamma probe.

Results: By intraoperatively injecting the radiotracer immediately after surgical exposure of the tumour, at least one sentinel lymph node could be detected in each patient, and the detection rate was 100%. The location of sentinel nodes was in the paracaval, renal hill, retro-aortic, para-aortic, common iliac, and external iliac areas, which was dependent on the tumour location. No false-negative case was identified.

Conclusions: Sentinel node mapping is feasible in UTUC. Injection technique (intra-vesical approach vs peri-tumoral injection after exposure of the tumour) and location of the tumour (proximal vs distal) may affect the technique's feasibility.

背景:利用放射性示踪剂作为定位材料,评估上尿路上皮癌(UTUC)前哨淋巴结定位的可行性。材料与方法:为识别前哨淋巴结,对5例肾盂癌或输尿管癌患者进行输尿管切除术和淋巴结切除术的候选患者注射37 MBq [99mTc]植酸盐。在手术暴露肿瘤后,以肿瘤周围的方式注射放射性示踪剂。前哨淋巴结用手持式伽玛探针检测。结果:手术暴露肿瘤后立即术中注射示踪剂,每位患者至少可检出1个前哨淋巴结,检出率为100%。前哨淋巴结位于下腔旁、肾丘、主动脉后、主动脉旁、髂总区和髂外区,与肿瘤位置有关。未发现假阴性病例。结论:前哨淋巴结定位在UTUC中是可行的。注射技术(肿瘤暴露后膀胱内入路vs肿瘤周围注射)和肿瘤的位置(近端vs远端)可能影响该技术的可行性。
{"title":"Sentinel lymph node biopsy in upper tract urothelial cancers: an experience with intraoperative radiotracer injection.","authors":"Leili Zarifmahmoudi,&nbsp;Hamidreza Ghorbani,&nbsp;Ramin Sadeghi,&nbsp;Salman Soltani,&nbsp;Kayvan Sadri,&nbsp;Mahmoud Tavakkoli,&nbsp;Maliheh Keshvari","doi":"10.5603/NMR.2021.0013","DOIUrl":"https://doi.org/10.5603/NMR.2021.0013","url":null,"abstract":"<p><strong>Background: </strong>The feasibility of the sentinel node mapping in upper tract urothelial cancers (UTUC) was evaluated, using a radiotracer as the mapping material.</p><p><strong>Material and methods: </strong>To identify the sentinel lymph nodes, 37 MBq of [99mTc] phytate was injected in five patients with the renal pelvis or ureter cancer, who were candidates for ureterectomy and lymphadenectomy. The radiotracer was injected in a peritumoral fashion following the surgical exposure of the tumour. The sentinel lymph nodes were detected using a handheld gamma probe.</p><p><strong>Results: </strong>By intraoperatively injecting the radiotracer immediately after surgical exposure of the tumour, at least one sentinel lymph node could be detected in each patient, and the detection rate was 100%. The location of sentinel nodes was in the paracaval, renal hill, retro-aortic, para-aortic, common iliac, and external iliac areas, which was dependent on the tumour location. No false-negative case was identified.</p><p><strong>Conclusions: </strong>Sentinel node mapping is feasible in UTUC. Injection technique (intra-vesical approach vs peri-tumoral injection after exposure of the tumour) and location of the tumour (proximal vs distal) may affect the technique's feasibility.</p>","PeriodicalId":44718,"journal":{"name":"NUCLEAR MEDICINE REVIEW","volume":"24 2","pages":"41-45"},"PeriodicalIF":0.9,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39303545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cholethorax with biliopleural communication detected on [99mTc]mebrofenin hepatobiliary scintigraphy. 用[99mTc]甲溴非宁肝胆显像检测胆胸膜连通的胆溶性胸氧症。
IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-01-01 DOI: 10.5603/NMR.2021.0031
Georgios Meristoudis, Ioannis Ilias, Evangelia Zaromytidou, Emmanouil Alevroudis, Athanasios Notopoulos

Bilious pleural effusion or cholethorax is a rare type of exudative pleural effusion. Here is presented a case of right-sided cholethorax, in which the direct communication between the pleural effusion with the biliary duct was visible only on the posteriori images of dynamic hepatobiliary scintigraphy with [99mTc]mebrofenin.

胆汁性胸腔积液是一种罕见的渗出性胸腔积液。本文报告一例右侧胆道绞痛,仅在使用[99mTc]甲溴非宁的动态肝胆造影后影上可见胸膜积液与胆管之间的直接连通。
{"title":"Cholethorax with biliopleural communication detected on [99mTc]mebrofenin hepatobiliary scintigraphy.","authors":"Georgios Meristoudis,&nbsp;Ioannis Ilias,&nbsp;Evangelia Zaromytidou,&nbsp;Emmanouil Alevroudis,&nbsp;Athanasios Notopoulos","doi":"10.5603/NMR.2021.0031","DOIUrl":"https://doi.org/10.5603/NMR.2021.0031","url":null,"abstract":"<p><p>Bilious pleural effusion or cholethorax is a rare type of exudative pleural effusion. Here is presented a case of right-sided cholethorax, in which the direct communication between the pleural effusion with the biliary duct was visible only on the posteriori images of dynamic hepatobiliary scintigraphy with [99mTc]mebrofenin.</p>","PeriodicalId":44718,"journal":{"name":"NUCLEAR MEDICINE REVIEW","volume":"24 2","pages":"124-125"},"PeriodicalIF":0.9,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39313950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung perfusion SPECT/CT images associated with COVID-19 - a case series. 与COVID-19相关的肺灌注SPECT/CT图像-一个病例系列
IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-01-01 DOI: 10.5603/NMR.2021.0009
Sara Kurkowska, Hanna Piwowarska-Bilska, Jacek Iwanowski, Bozena Birkenfeld
Coronavirus disease 2019 (COVID-19) most often presents with mild symptoms, but it can also present with viral pneumonia and acute respiratory distress syndrome, which predispose to thromboembolic disease. There is an increasing number of case studies which report the significance of ventilation/perfusion scintigraphy in the diagnosis of pulmonary embolism in COVID-19 patients [1, 2]. Since most of the patients in Poland were managed in an outpatient setting, this population has been excluded from many studies and its characteristics are not well-documented. Dhawan et al. [3] emphasize the importance of the evaluation of the prevalence and extent of perfusion abnormalities in survivors of COVID-19 through the whole spectrum of illness, from non-hospitalised patients to those in the intensive care unit (ICU). We report a case series of three patients after recovery from COVID-19, who underwent lung perfusion SPECT/CT. Scintigraphic examinations were performed after administration of 99mTc-Makro-Albumon with an activity of about 2 MBq/kg of patient’s body weight. All patients were examined using Symbia Intevo Bold with a protocol including SPECT/CT acquisition with the following parameters: LEHR collimator, 360 degrees, 120 projections, time per projection 15 sec, matrix 128x128; low-dose CT protocol. The examinations were performed to assess lung lesions in these patients. All patients were diagnosed through RT-PCR for SARS-CoV2 and were presenting mild-to-moderate symptoms. Treatment was symptomatic, including paracetamol and ibuprofen in all patients and additional azithromycin in case of Patient 1. None of them required hospitalization. Data and perfusion SPECT/CT findings of the patients are presented in the Table 1 below. Figure 1 and 2 show SPECT/CT findings of Patients 1 and 3, respectively.
{"title":"Lung perfusion SPECT/CT images associated with COVID-19 - a case series.","authors":"Sara Kurkowska,&nbsp;Hanna Piwowarska-Bilska,&nbsp;Jacek Iwanowski,&nbsp;Bozena Birkenfeld","doi":"10.5603/NMR.2021.0009","DOIUrl":"https://doi.org/10.5603/NMR.2021.0009","url":null,"abstract":"Coronavirus disease 2019 (COVID-19) most often presents with mild symptoms, but it can also present with viral pneumonia and acute respiratory distress syndrome, which predispose to thromboembolic disease. There is an increasing number of case studies which report the significance of ventilation/perfusion scintigraphy in the diagnosis of pulmonary embolism in COVID-19 patients [1, 2]. Since most of the patients in Poland were managed in an outpatient setting, this population has been excluded from many studies and its characteristics are not well-documented. Dhawan et al. [3] emphasize the importance of the evaluation of the prevalence and extent of perfusion abnormalities in survivors of COVID-19 through the whole spectrum of illness, from non-hospitalised patients to those in the intensive care unit (ICU). We report a case series of three patients after recovery from COVID-19, who underwent lung perfusion SPECT/CT. Scintigraphic examinations were performed after administration of 99mTc-Makro-Albumon with an activity of about 2 MBq/kg of patient’s body weight. All patients were examined using Symbia Intevo Bold with a protocol including SPECT/CT acquisition with the following parameters: LEHR collimator, 360 degrees, 120 projections, time per projection 15 sec, matrix 128x128; low-dose CT protocol. The examinations were performed to assess lung lesions in these patients. All patients were diagnosed through RT-PCR for SARS-CoV2 and were presenting mild-to-moderate symptoms. Treatment was symptomatic, including paracetamol and ibuprofen in all patients and additional azithromycin in case of Patient 1. None of them required hospitalization. Data and perfusion SPECT/CT findings of the patients are presented in the Table 1 below. Figure 1 and 2 show SPECT/CT findings of Patients 1 and 3, respectively.","PeriodicalId":44718,"journal":{"name":"NUCLEAR MEDICINE REVIEW","volume":"24 1","pages":"35-36"},"PeriodicalIF":0.9,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25364678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
In memoriam - Prof. Anna Celler. 纪念安娜·塞勒教授。
IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-01-01 DOI: 10.5603/NMR.2021.0011
Bozena Birkenfeld, Renata Mikolajczak
{"title":"In memoriam - Prof. Anna Celler.","authors":"Bozena Birkenfeld,&nbsp;Renata Mikolajczak","doi":"10.5603/NMR.2021.0011","DOIUrl":"https://doi.org/10.5603/NMR.2021.0011","url":null,"abstract":"","PeriodicalId":44718,"journal":{"name":"NUCLEAR MEDICINE REVIEW","volume":"24 1","pages":"37-39"},"PeriodicalIF":0.9,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25364679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial. 社论。
IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-01-01 DOI: 10.5603/NMR.2021.0010
Grzegorz Kamiński
{"title":"Editorial.","authors":"Grzegorz Kamiński","doi":"10.5603/NMR.2021.0010","DOIUrl":"https://doi.org/10.5603/NMR.2021.0010","url":null,"abstract":"","PeriodicalId":44718,"journal":{"name":"NUCLEAR MEDICINE REVIEW","volume":"24 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25364670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the usefulness of positron emission tomography with [18F]fluorodeoxylglucose performed to detect non-radioiodine avid recurrence and/or metastasis of differentiated thyroid cancer - a preliminary study. 评价[18F]氟脱氧葡萄糖正电子发射断层扫描检测分化型甲状腺癌非放射性碘复发和/或转移的有效性-一项初步研究。
IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-01-01 DOI: 10.5603/NMR.2021.0017
Maciej Kolodziej, Marek Saracyn, Arkadiusz Lubas, Dorota Brodowska-Kania, Andrzej Mazurek, Mirosław Dziuk, Jolanta Dymus, Grzegorz Kaminski
<p><strong>Background: </strong>About 30% of patients with disseminated differentiated thyroid cancer (DTC) may experience a loss of iodine uptake. It is associated with higher aggressiveness of the tumour and a reduced 10-year survival rate. The diagnosis of non-radioiodine avid DTC metastases remains a diagnostic challenge. A helpful technique for this diagnosis is positron emission tomography with 2-[¹⁸F]fluoro-2-deoxy-D-glucose (PET/CT with [¹⁸F]FDG). On the other hand, there are still discussions about the clinical value of using exogenous thyroid-stimulating hormone (TSH) stimulation before PET/CT with [¹⁸F]FDG. The aim of the study was the assessment of the usefulness of PET/CT with [¹⁸F]FDG under TSH suppression and stimulation of TSH performed in the detection of non-radioiodine avid DTC metastases, as well as determination of the thyroglobulin concentration under suppression and stimulation of TSH, which influences the result of PET/CT with [¹⁸F]FDG in patients with non-radioiodine avid DTC.</p><p><strong>Material and methods: </strong>Retrospective analysis of 37 PET/CT with [¹⁸F]FDG performed in patients with DTC diagnosed and treated at the Department of Endocrinology and Isotope Therapy of the Military Institute of Medicine from January 2018 to July 2020. Of these, PET/CT with [¹⁸F]FDG under exogenous rhTSH stimulation was performed in 22 patients and PET/CT with [¹⁸F]FDG under TSH suppression in 15 was performed. In all analyzed patients, the result of diagnostic whole-body scintigraphy (WBS) using 80 MBq ¹³¹I under rhTSH stimulation was negative, and the concentration of thyroglobulin after stimulation (sTg) was greater than 1.0 ng/mL.</p><p><strong>Results: </strong>In the group of patients examined under TSH suppression, non-radioiodine avid in PET/CT with [¹⁸F]FDG were found in 6 out of 15 patients (40%) and in the group of patients examined under rhTSH stimulation in 10 out of 22 patients (45%). The differences between the groups were not statistically significant. The analysis of the receiver operating characteristic (ROC) curves allowed to determine the cut-off point for the positive result of PET/CT performed under TSH suppression with sTg concentration of 11.03 ng/mL. In the group of studies performed under rhTSH stimulation, the cut-off point for sTg was 6.3 ng/mL. There was no statistically significant difference between the baseline thyroglobulin (natTg) and sTg levels and the positive PET/CT result. The administration of rhTSH before the PET/CT examination also had no statistically significant effect on the maximum standard uptake value (SUVmax) of the dominant lesion identified in the PET/CT.</p><p><strong>Conclusions: </strong>1) PET/CT with [¹⁸F]FDG is a useful tool for detection of non-radioiodine avid recurrence and/or metastases of DTC. 2) The concentration of natTg and sTg is highly correlated with a positive result of PET/CT with [¹⁸F]FDG. 3) The concentration of natTg is comparable with sTg in predicting a pos
背景:约30%的弥散性分化型甲状腺癌(DTC)患者可能出现碘摄取缺失。它与肿瘤的高侵袭性和10年生存率降低有关。诊断非放射性碘性DTC转移仍然是一个诊断挑战。2-[¹⁸F]氟-2-脱氧-d -葡萄糖正电子发射断层扫描(PET/CT +[¹⁸F]FDG)是一种有用的诊断技术。另一方面,对于[¹⁸F]FDG在PET/CT前使用外源性促甲状腺激素(TSH)刺激的临床价值仍有讨论。本研究的目的是评估[¹⁸F]FDG在TSH抑制和TSH刺激下PET/CT检测非放射性碘依赖型DTC转移的有效性,以及测定TSH抑制和刺激下甲状腺球蛋白浓度对[¹⁸F]FDG在非放射性碘依赖型DTC患者中检测结果的影响。材料与方法:回顾性分析2018年1月至2020年7月在军事医学研究所内分泌与同位素治疗科诊断和治疗的37例DTC患者的PET/CT扫描[¹⁸F]FDG。其中,22例患者在外源性rhTSH刺激下使用[¹⁸F]FDG进行PET/CT检查,15例患者在TSH抑制下使用[¹⁸F]FDG进行PET/CT检查。在所有分析的患者中,rhTSH刺激下使用80 MBq¹³¹I的诊断性全身显像(WBS)结果均为阴性,刺激后甲状腺球蛋白(sTg)浓度均大于1.0 ng/mL。结果:在TSH抑制组中,PET/CT显示[¹⁸F]FDG的15例患者中有6例(40%)存在非放射性碘缺乏,而在rhTSH刺激组中22例患者中有10例(45%)存在非放射性碘缺乏。两组间差异无统计学意义。通过对受试者工作特征(ROC)曲线的分析,确定了sTg浓度为11.03 ng/mL时TSH抑制下PET/CT阳性结果的截断点。在rhTSH刺激下进行的一组研究中,sTg的临界值为6.3 ng/mL。基线甲状腺球蛋白(natTg)和sTg水平与PET/CT阳性结果之间无统计学差异。在PET/CT检查前给药rhTSH对PET/CT发现的优势病变的最大标准摄取值(SUVmax)也没有统计学意义上的影响。结论:1)PET/CT检测[¹⁸F]FDG是检测非放射性碘性复发和/或转移性DTC的有效工具。2) natTg和sTg浓度与PET/CT检测[¹⁸F]FDG阳性呈高度相关。3) natTg浓度与sTg浓度在预测[¹⁸F]FDG PET/CT阳性结果方面具有可比性。4) PET/CT检测natTg阳性结果的临界值为1.36 ng/mL, sTg阳性结果的临界值为7.05 ng/mL。
{"title":"Evaluation of the usefulness of positron emission tomography with [18F]fluorodeoxylglucose performed to detect non-radioiodine avid recurrence and/or metastasis of differentiated thyroid cancer - a preliminary study.","authors":"Maciej Kolodziej,&nbsp;Marek Saracyn,&nbsp;Arkadiusz Lubas,&nbsp;Dorota Brodowska-Kania,&nbsp;Andrzej Mazurek,&nbsp;Mirosław Dziuk,&nbsp;Jolanta Dymus,&nbsp;Grzegorz Kaminski","doi":"10.5603/NMR.2021.0017","DOIUrl":"https://doi.org/10.5603/NMR.2021.0017","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;About 30% of patients with disseminated differentiated thyroid cancer (DTC) may experience a loss of iodine uptake. It is associated with higher aggressiveness of the tumour and a reduced 10-year survival rate. The diagnosis of non-radioiodine avid DTC metastases remains a diagnostic challenge. A helpful technique for this diagnosis is positron emission tomography with 2-[¹⁸F]fluoro-2-deoxy-D-glucose (PET/CT with [¹⁸F]FDG). On the other hand, there are still discussions about the clinical value of using exogenous thyroid-stimulating hormone (TSH) stimulation before PET/CT with [¹⁸F]FDG. The aim of the study was the assessment of the usefulness of PET/CT with [¹⁸F]FDG under TSH suppression and stimulation of TSH performed in the detection of non-radioiodine avid DTC metastases, as well as determination of the thyroglobulin concentration under suppression and stimulation of TSH, which influences the result of PET/CT with [¹⁸F]FDG in patients with non-radioiodine avid DTC.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Material and methods: &lt;/strong&gt;Retrospective analysis of 37 PET/CT with [¹⁸F]FDG performed in patients with DTC diagnosed and treated at the Department of Endocrinology and Isotope Therapy of the Military Institute of Medicine from January 2018 to July 2020. Of these, PET/CT with [¹⁸F]FDG under exogenous rhTSH stimulation was performed in 22 patients and PET/CT with [¹⁸F]FDG under TSH suppression in 15 was performed. In all analyzed patients, the result of diagnostic whole-body scintigraphy (WBS) using 80 MBq ¹³¹I under rhTSH stimulation was negative, and the concentration of thyroglobulin after stimulation (sTg) was greater than 1.0 ng/mL.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;In the group of patients examined under TSH suppression, non-radioiodine avid in PET/CT with [¹⁸F]FDG were found in 6 out of 15 patients (40%) and in the group of patients examined under rhTSH stimulation in 10 out of 22 patients (45%). The differences between the groups were not statistically significant. The analysis of the receiver operating characteristic (ROC) curves allowed to determine the cut-off point for the positive result of PET/CT performed under TSH suppression with sTg concentration of 11.03 ng/mL. In the group of studies performed under rhTSH stimulation, the cut-off point for sTg was 6.3 ng/mL. There was no statistically significant difference between the baseline thyroglobulin (natTg) and sTg levels and the positive PET/CT result. The administration of rhTSH before the PET/CT examination also had no statistically significant effect on the maximum standard uptake value (SUVmax) of the dominant lesion identified in the PET/CT.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;1) PET/CT with [¹⁸F]FDG is a useful tool for detection of non-radioiodine avid recurrence and/or metastases of DTC. 2) The concentration of natTg and sTg is highly correlated with a positive result of PET/CT with [¹⁸F]FDG. 3) The concentration of natTg is comparable with sTg in predicting a pos","PeriodicalId":44718,"journal":{"name":"NUCLEAR MEDICINE REVIEW","volume":"24 2","pages":"63-69"},"PeriodicalIF":0.9,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39303508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Infection of aortobifemoral bypass graft implanted 20 years ago proved by labeled leukocytes SPECT-CT. 标记白细胞SPECT-CT证实20年前主动脉股动脉旁路移植术感染。
IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-01-01 DOI: 10.5603/NMR.a2021.0027
Olgierd Chrabanski, Tomasz Golab
Correspondence to: Olgierd Chrabanski, Department of Radiodiagnostics, Invasive Radiology and Nuclear Medicine, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland, e-mail: olgierdchrabanski@gmail.com Aortic graft infections are very serious complications of arterial reconstructive surgery. The described in literature longest interval between primary reconstruction and aortic graft infections was 20 years [1]. This research reports a case of a 60-year-old man with a suspected infection of an aortobifemoral bypass graft implanted 20 years ago due to an aneurysm of the abdominal aorta. He was referred to a nuclear medicine department for scintigraphic detection or exclusion of active infection within the stent-graft. The patient had many comorbidities: renal failure, arterial hypertension, hypertensive cardiomyopathy, ischemic heart disease. This year, the patient underwent thrombosis of the left saphenous vein with cellulitis of the left leg and was treated surgically due to an abscess of the left buttock. Laboratory tests revealed: leukocytosis, significantly elevated CRP and anaemia. Enterococcus faecalis susceptible to ampicillin, teicoplanin and vancomycin were grown on venous blood cultures. Despite the implementation of antibiotic therapy, no significant improvement in the patient’s clinical condition was achieved. The computed tomography examination showed changes suggesting infection of the vascular prosthesis. Due to the high risk of the surgery, it was decided to operate after obtaining scintigraphic detection of infection within the stentgraft. The examination was performed with Technetium-99m labelled leukocytes using HMPAO. The patient was examined 1, 4 and 24 hours after radiotracer injection using Symbia Intevo with a protocol including SPECT/CT with LEHR collimator, low-dose CT.
{"title":"Infection of aortobifemoral bypass graft implanted 20 years ago proved by labeled leukocytes SPECT-CT.","authors":"Olgierd Chrabanski,&nbsp;Tomasz Golab","doi":"10.5603/NMR.a2021.0027","DOIUrl":"https://doi.org/10.5603/NMR.a2021.0027","url":null,"abstract":"Correspondence to: Olgierd Chrabanski, Department of Radiodiagnostics, Invasive Radiology and Nuclear Medicine, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland, e-mail: olgierdchrabanski@gmail.com Aortic graft infections are very serious complications of arterial reconstructive surgery. The described in literature longest interval between primary reconstruction and aortic graft infections was 20 years [1]. This research reports a case of a 60-year-old man with a suspected infection of an aortobifemoral bypass graft implanted 20 years ago due to an aneurysm of the abdominal aorta. He was referred to a nuclear medicine department for scintigraphic detection or exclusion of active infection within the stent-graft. The patient had many comorbidities: renal failure, arterial hypertension, hypertensive cardiomyopathy, ischemic heart disease. This year, the patient underwent thrombosis of the left saphenous vein with cellulitis of the left leg and was treated surgically due to an abscess of the left buttock. Laboratory tests revealed: leukocytosis, significantly elevated CRP and anaemia. Enterococcus faecalis susceptible to ampicillin, teicoplanin and vancomycin were grown on venous blood cultures. Despite the implementation of antibiotic therapy, no significant improvement in the patient’s clinical condition was achieved. The computed tomography examination showed changes suggesting infection of the vascular prosthesis. Due to the high risk of the surgery, it was decided to operate after obtaining scintigraphic detection of infection within the stentgraft. The examination was performed with Technetium-99m labelled leukocytes using HMPAO. The patient was examined 1, 4 and 24 hours after radiotracer injection using Symbia Intevo with a protocol including SPECT/CT with LEHR collimator, low-dose CT.","PeriodicalId":44718,"journal":{"name":"NUCLEAR MEDICINE REVIEW","volume":"24 2","pages":"115-117"},"PeriodicalIF":0.9,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39313949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accumulation of 99m-Tc Phytate in the pyelocalyceal system in a patient with chylous ascites - a pitfall resolved by SPECT/CT. 一名乳糜腹水患者的肾盂系统中积聚了 99m-Tc Phytate--SPECT/CT 解决了这一隐患。
IF 0.6 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-01-01 DOI: 10.5603/NMR.2021.0006
Hadis Mohammadzadeh Kosari, Somayeh Barashki, Yasaman Fakhar, Emran Askari, Ramin Sadeghi

We reported 99m-Tc phytate accumulation in the pyelocalyceal system of the kidney in the lymphoscintigraphic images of a 3.5 months-old male infant with chylous ascites, which was mistaken with the site of lymph leakage. SPECT/CT localized activity in the para-aortic region to the renal pelvis and on delayed images, this was disappeared. Our case illustrates the added value of SPECT/CT for the differentiation of possible false-positive findings in lymphoscintigraphy.

我们报告了一名 3 个半月大的患有乳糜腹水的男婴的淋巴管造影图像中肾盂萼膜系统的 99m-Tc 植酸积聚,这被误认为是淋巴漏的部位。SPECT/CT 将主动脉旁区域的活动定位到肾盂,在延迟图像上,活动消失了。我们的病例说明了 SPECT/CT 在区分淋巴管造影中可能出现的假阳性结果方面的附加价值。
{"title":"Accumulation of 99m-Tc Phytate in the pyelocalyceal system in a patient with chylous ascites - a pitfall resolved by SPECT/CT.","authors":"Hadis Mohammadzadeh Kosari, Somayeh Barashki, Yasaman Fakhar, Emran Askari, Ramin Sadeghi","doi":"10.5603/NMR.2021.0006","DOIUrl":"10.5603/NMR.2021.0006","url":null,"abstract":"<p><p>We reported 99m-Tc phytate accumulation in the pyelocalyceal system of the kidney in the lymphoscintigraphic images of a 3.5 months-old male infant with chylous ascites, which was mistaken with the site of lymph leakage. SPECT/CT localized activity in the para-aortic region to the renal pelvis and on delayed images, this was disappeared. Our case illustrates the added value of SPECT/CT for the differentiation of possible false-positive findings in lymphoscintigraphy.</p>","PeriodicalId":44718,"journal":{"name":"NUCLEAR MEDICINE REVIEW","volume":"24 1","pages":"29-30"},"PeriodicalIF":0.6,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25364675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fever of Unknown Origin - infected Fistula-in-Ano as the focus on 18F-FDG PET-CT. 不明原因的发热--感染性肛瘘是 18F-FDG PET-CT 的重点。
IF 0.6 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-01-01 DOI: 10.5603/NMR.2021.0007
Punit Sharma

Fever of Unknown Origin (FUO) is a vexing clinical problem. Diagnosis of aetiology is essential for definitive management. A wide array of infective, inflammatory, malignant and miscellaneous pathologies can cause FUO. Hybrid imaging with 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET-CT) is now an integral part of FUO management because of its ability to demonstrate the cause in a large proportion of cases. The authors present the case of a 42-year-old male, where an infected fistula-in-ano was detected as the cause of FUO on 18F-FDG PET-CT.

不明原因发热(FUO)是一个令人头疼的临床问题。病因诊断对于明确治疗至关重要。一系列感染性、炎症性、恶性和其他病变均可导致不明原因发热。使用 18F-FDG 正电子发射断层扫描-计算机断层扫描(PET-CT)进行混合成像现在已成为 FUO 治疗不可或缺的一部分,因为它能在很大比例的病例中显示病因。作者介绍了一例 42 岁男性的病例,18F-FDG PET-CT 发现其 FUO 的病因是感染性肛瘘。
{"title":"Fever of Unknown Origin - infected Fistula-in-Ano as the focus on 18F-FDG PET-CT.","authors":"Punit Sharma","doi":"10.5603/NMR.2021.0007","DOIUrl":"10.5603/NMR.2021.0007","url":null,"abstract":"<p><p>Fever of Unknown Origin (FUO) is a vexing clinical problem. Diagnosis of aetiology is essential for definitive management. A wide array of infective, inflammatory, malignant and miscellaneous pathologies can cause FUO. Hybrid imaging with 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET-CT) is now an integral part of FUO management because of its ability to demonstrate the cause in a large proportion of cases. The authors present the case of a 42-year-old male, where an infected fistula-in-ano was detected as the cause of FUO on 18F-FDG PET-CT.</p>","PeriodicalId":44718,"journal":{"name":"NUCLEAR MEDICINE REVIEW","volume":"24 1","pages":"31-32"},"PeriodicalIF":0.6,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25364676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
NUCLEAR MEDICINE REVIEW
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1